Multiple Targets, One Goal: Compounding life-extending effects through Polypharmacology
Avchaciov, K.; Clay, K. J.; Burmistrova, O.; Petrascheck, M.; Fedichev, P. O.
Show abstract
Analysis of lifespan-extending compounds suggested the most effective geroprotectors target multiple biogenic amine receptors. To test this hypothesis, we used graph neural networks to predict such polypharmacological compounds and evaluated them in C. elegans. Over 70% of the selected compounds extended lifespan, with effect sizes in the top 5% compared to the DrugAge database. This reveals that rationally designing polypharmacological compounds enables the design of geroprotectors with exceptional efficacy. Key takeawaysO_LIThe most effective known geroprotectors act by polypharmacological mechanisms. C_LIO_LIGraph neural networks predicted polypharmacological geroprotectors with a hit rate of 70%. C_LIO_LIThe predicted polypharmacological geroprotectors are exceptionally effective. C_LIO_LIThe predicted polypharmacological mechanism was experimentally confirmed. C_LIO_LIRationally designing polypharmacological compounds results in geroprotectors with exceptional efficacy. C_LI
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Sex-specific insights into drug-induced lifespan extension and weight loss in mice 94%
- Mitorubin, berberrubine-based compounds that improve mitochondrial function, exhibit cardioprotective effects against age-related cardiac dysfunction 92%
- Cyrene: A Novel Geroprotective Compound that Extends Lifespan and Healthspan in C. elegans and Drosophila 91%
Similar papers in this journal
- Deciphering the Timing and Impact of Life-extending Interventions: Temporal Efficacy Profiler Distinguishes Early, Midlife, and Senescence Phase Efficacies 94%
- Machine Learning Identifies Novel Candidates for DrugRepurposing in Alzheimer's Disease 93%
- A novel preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs 93%
Similar papers in this journal
- From atoms to cells: bridging the gap between potency, efficacy, and safety of small molecules directed at a membrane protein 92%
- PKIS Deep Dive Yields a Chemical Starting Point for Dark Kinases and a Cell Active BRSK2 Inhibitor 92%
- Tales of 1,008 Small Molecules: Phenomic Profiling through Live-cell Imaging in a Panel of Reporter Cell Lines 92%
Similar papers in this journal
- Structure-aided development of small molecule inhibitors of ENPP1, the extracellular phosphodiesterase of the immunotransmitter cGAMP 94%
- An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor. 92%
- Management of Hsp90-Dependent Protein Folding by Small Molecule Targeting the Aha1 Co-Chaperone 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.